124.43
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
What to do if you’re stuck in Jazz Pharmaceuticals plc2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Using data filters to optimize entry into Jazz Pharmaceuticals plcJuly 2025 Opening Moves & Consistent Profit Trade Alerts - Newser
Has Jazz Pharmaceuticals plc formed a bullish divergenceWatch List & Verified Short-Term Plans - Newser
13 Best Mid Cap Growth Stocks to Buy According to Hedge Funds - Insider Monkey
Is Jazz Pharmaceuticals plc stock entering bullish territoryPortfolio Performance Summary & Real-Time Sentiment Analysis - Newser
Real Time Chart Alerts Flash Bullish on Jazz Pharmaceuticals plc2025 Analyst Calls & Smart Money Movement Tracker - beatles.ru
Risk vs reward if holding onto Jazz Pharmaceuticals plc2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Will Jazz Pharmaceuticals plc bounce back from current supportJuly 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
News impact scoring models applied to Jazz Pharmaceuticals plcJuly 2025 Update & Safe Capital Allocation Plans - Newser
Pattern recognition hints at Jazz Pharmaceuticals plc upsideLayoff News & Scalable Portfolio Growth Methods - Newser
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug - MSN
Using data tools to time your Jazz Pharmaceuticals plc exitWeekly Gains Summary & Verified Entry Point Signals - Newser
Analyzing recovery setups for Jazz Pharmaceuticals plc investorsChart Signals & Low Volatility Stock Suggestions - Newser
What technical models suggest about Jazz Pharmaceuticals plc’s comebackWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser
Can Jazz Pharmaceuticals plc recover in the next quarterPortfolio Gains Report & Risk Controlled Daily Plans - Newser
Chart overlay techniques for tracking Jazz Pharmaceuticals plcForecast Cut & High Win Rate Trade Alerts - Newser
US Narcolepsy Drugs Market Outlook and Company Analysis Report 2025-2033 Featuring Jazz Pharma, Liga - PharmiWeb.com
Can Jazz Pharmaceuticals plc grow without dilution2025 Top Gainers & Consistent Profit Trading Strategies - sundaytimes.kr
Jazz Pharmaceuticals’ Zanidatamab Study: A New Hope for Metastatic Breast Cancer? - TipRanks
Developing predictive dashboards with Jazz Pharmaceuticals plc dataPortfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser
Jazz Pharmaceuticals plc Earnings Report Breakdown: What Investors Should Know2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Is Jazz Pharmaceuticals plc stock a smart retirement pick2025 Risk Factors & Real-Time Volume Surge Alerts - theviewers.co.kr
Combining machine learning predictions for Jazz Pharmaceuticals plcWall Street Watch & Growth-Oriented Investment Plans - Newser
BofA Raises PT on Jazz Pharmaceuticals (JAZZ) to $225 From $217 - MSN
Jazz Pharmaceuticals to Present at 2025 Wells Fargo Healthcare Conference - AInvest
Jazz Pharmaceuticals (JAZZ): Valuation in Focus After Major Epilepsy Drug Deal and Leadership Change - simplywall.st
Jazz Pharmaceuticals to Participate in Wells Fargo Healthcare Conference - AInvest
Global Biopharma Leader Jazz Pharmaceuticals to Share Updates at Wells Fargo Healthcare Conference 2025 - Stock Titan
Will Breakout in Jazz Pharmaceuticals plc Sustain Through Next WeekQuarterly Portfolio Review & Technical Pattern Based Buy Signals - 더경남뉴스
Jazz Pharmaceuticals Acquires Rights to Epilepsy Drug SAN2355 for $1B, Aims to Expand Neuroscience Pipeline - AInvest
Jazz gains rights to Saniona’s SAN-2355 - BioWorld MedTech
Earnings call transcript: Jazz Pharmaceuticals’ Q2 2025 earnings miss expectations, stock drops - Investing.com
AI Indicators Detect Buy Opportunity in Jazz Pharmaceuticals plcJuly 2025 Volume & Fast Gain Stock Trading Tips - 더경남뉴스
What MACD signals say about Jazz Pharmaceuticals plcVolume Spike & Comprehensive Market Scan Insights - Newser
Jazz Seeks Potential Expansion Of Epilepsy Franchise With Saniona Deal - insights.citeline.com
Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025 - WV News
Jazz pharmaceuticals acquires rights to Saniona’s epilepsy drug candidate By Investing.com - Investing.com Nigeria
Jazz Pharmaceuticals, Saniona Enter Exclusive Agreement - Contract Pharma
Why Jazz Pharmaceuticals (JAZZ) Is Up 5.2% After Modeyso Receives FDA Approval for Rare Brain Cancer - simplywall.st
Jazz pharmaceuticals acquires rights to Saniona’s epilepsy drug candidate - Investing.com
Jazz Pharmaceuticals licenses epilepsy drug from Saniona for $42.5M - StreetInsider
$1 Billion Deal: Jazz Pharma Secures Rights to Revolutionary Epilepsy Drug SAN2355 from Saniona - Stock Titan
Jazz Pharmaceuticals price target lowered to $165 from $166 at Morgan Stanley - MSN
Price action breakdown for Jazz Pharmaceuticals plcDollar Strength & Fast Moving Stock Trade Plans - Newser
Ligand to Participate in September Investor Conferences - GlobeNewswire Inc.
Using flow based indicators on Jazz Pharmaceuticals plcMarket Performance Summary & Low Risk High Win Rate Stock Picks - Newser
Jazz Pharmaceuticals plc Shows Early Signs of Technical Strength2025 Pullback Review & Expert Verified Movement Alerts - kangso.co.kr
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):